Jarred Lau Successful in Master’s Defense

The Lochmüller Lab would like to congratulate Master’s student Jarred Lau on successfully defending his thesis this month!

Jarred’s thesis looked at unsolved patients with congenital myasthenic syndromes (CMS), a rare inherited neuromuscular disease caused by disrupted signal transmission at the neuromuscular junction (NMJ). Analysis of these patients’ exome data revealed novel gene candidates for CMS. As an experimental model, Jarred knocked down genetic orthologues in zebrafish and used functional experiments to elicit their neuromuscular role. His study found that knockdown of one of the candidate genes is enough to cause significant decreases in key developmental motor behaviors and abnormal development of the zebrafish neuromuscular system. This evidence lends strong support that disruption of this gene candidate could cause CMS.

To solidify this claim, Jarred will continue work in the Lochmuller lab, investigating roles of candidate CMS genes at the NMJ using electrophysiology studies in zebrafish.

Jarred_Defense

Read next...

welcome

Meet The Lab’s New Clinical Members!

Our research team is growing! We are excited to announce three new research staff who have joined the lab this winter, as well as two...
researcher of the year 2025

Dr. Hanns Lochmüller Awarded “Clinical Researcher of the Year” by University of Ottawa Faculty of Medicine

We are thrilled to announce that Dr. Hanns Lochmüller has been awarded the Clinical Researcher of the Year Award by the University of Ottawa Faculty...
Holland study

New Publication: Galactose treatment rescues neuromuscular junction transmission in glutamine-fructose-6-phosphate transaminase 1 (Gfpt1) deficient mice

Congenital Myasthenic Syndromes (CMS) are a group of rare inherited neuromuscular disorders caused by genetic defects at the neuromuscular junction (NMJ). Patients with CMS experience...
award winners

Celebrating Lab Members’ Recent Research Awards

We are thrilled to celebrate Kelly Ho for receiving first place for her poster presentation at this year’s American Society for Pharmacology and Experimental Therapeutics...
New publication - RTD (2)

Meet The Lochmüller Lab’s Newest Members!

Our research team is growing! We are excited to introduce three new members who have recently joined the Lochmüller lab and several students who will...
McMillan smart study (1)

New Clinical Study Examines Safety and Efficacy of IV Onasemnogene Abeparvovec in Broad SMA Cohort

Pediatric neurologist Dr Hugh McMillan publishes clinical study examining the safety and efficacy of IV onasemnogene abeparvovec in the broadest cohort of SMA patients to...